OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study

Supralimus-Core™ Pharmacokinetic (PK) Study

NCT01121744 ·Status: COMPLETED ·Phase: NA

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

NCT07190690 ·Status: RECRUITING ·Phase: NA

Drug Eluting Stent (DES) in Primary Angioplasty

NCT00759850 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation

NCT02504307 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

NCT02579031 ·Status: COMPLETED ·Phase: NA

Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

NCT00752362 ·Status: COMPLETED ·Phase: PHASE4

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT04175626 ·Status: COMPLETED

Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions

NCT01507519 ·Status: COMPLETED ·Phase: NA

First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease

NCT01247428 ·Status: COMPLETED ·Phase: PHASE2

Xience Versus Synergy in Left Main PCI

NCT02303717 ·Status: UNKNOWN ·Phase: NA

Optimal Stent Deployment Strategy of Contemporary Stents

NCT05292651 ·Status: RECRUITING ·Phase: NA

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)

NCT01078038 ·Status: COMPLETED ·Phase: PHASE4

Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents

NCT00598715 ·Status: COMPLETED ·Phase: PHASE4

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

NCT00233818 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.

NCT03721614 ·Status: UNKNOWN ·Phase: NA

Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome

NCT02049229 ·Status: UNKNOWN ·Phase: PHASE4

Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT

NCT01405287 ·Status: COMPLETED ·Phase: PHASE2

XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization

NCT03745053 ·Status: COMPLETED ·Phase: NA

Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease

NCT01294748 ·Status: COMPLETED ·Phase: PHASE2

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

NCT00231257 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing the MiStent SES Versus the XIENCE EES Stent

NCT02385279 ·Status: COMPLETED ·Phase: NA

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT02389946 ·Status: COMPLETED ·Phase: NA

Study of the Orsiro Drug Eluting Stent System

NCT01356888 ·Status: UNKNOWN ·Phase: NA

SELUTION 4 De Novo Small Vessel IDE Trial

NCT05946629 ·Status: RECRUITING ·Phase: NA

Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent

NCT00793221 ·Status: COMPLETED ·Phase: PHASE3